MarketCap
Facebook
X
Telegram
Anixa Biosciences ROE Ratio | ANIX
Annual ROE Ratio Anixa Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -72.07 | -62.78 | -40.31 | -46.8 | -36.55 | -122.12 | -242.02 | -270.01 | -63.22 | -508.01 | -27.29 | -239.58 | 303.56 | 356.16 | -697.34 | -112.6 | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 356.16 | -697.34 | -117.56 |
Quarterly ROE Ratio Anixa Biosciences
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -63.48 | -65.01 | -65.0 | -67.03 | -50.02 | -65.86 | -66.15 | -62.02 | -42.97 | -53.18 | -46.17 | -40.9 | -27.67 | -62.51 | -61.18 | -63.63 | -71.24 | -61.63 | -64.84 | -60.32 | -91.7 | -155.44 | -172.59 | -195.95 | -238.98 | -332.61 | -344.25 | -363.3 | -301.22 | -281.49 | -341.39 | -317.57 | -194.78 | -72.6 | 5.53 | 32.92 | -105.67 | -466.89 | -556.02 | -686.85 | -597.05 | -196.85 | -116.78 | -32.24 | -13.92 | -173.15 | -131.19 | -167.98 | -73.5 | 302.86 | 370.37 | 525.99 | 247.68 | 188.07 | 163.01 | 161.88 | 18.13 | -305.31 | -479.64 | -553.09 | -263.83 | -167.62 | -121.64 |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 525.99 | -686.85 | -123.13 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Fulgent Genetics
FLGT
|
-5.44 | $ 25.83 | -1.22 % | $ 795 M |  USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 80.78 | -4.31 % | $ 4.3 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Biomerica
BMRA
|
-143.54 | $ 1.48 | -4.52 % | $ 4.31 M | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 7.0 | -13.43 % | $ 31 M | USA |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.49 | $ 204.62 | -1.43 % | $ 16 B |  Irlanda |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 0.29 | -9.5 % | $ 386 K | USA |
 |
Burning Rock Biotech Limited
BNR
|
-10.34 | $ 13.19 | 6.46 % | $ 135 M |  China |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
DarioHealth Corp.
DRIO
|
-61.41 | $ 2.37 | 15.05 % | $ 9.44 M |  Israel |
 |
Myriad Genetics
MYGN
|
-99.46 | $ 5.66 | -1.39 % | $ 524 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-310.93 | $ 4.78 | -1.24 % | $ 3.76 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | $ 50.52 | -0.07 % | $ 11 B |  Niderland |
 |
NeoGenomics
NEO
|
-12.91 | $ 16.97 | -3.58 % | $ 2.17 B | USA |
 |
OPKO Health
OPK
|
-17798.68 | $ 1.71 | 0.58 % | $ 1.28 B | USA |
 |
Pacific Biosciences of California
PACB
|
-10214.99 | $ 2.22 | -5.93 % | $ 666 M | USA |
 |
Neogen Corporation
NEOG
|
-0.38 | $ 11.67 | -3.44 % | $ 2.54 B | USA |
 |
Precipio
PRPO
|
-2.49 | $ 23.56 | 6.13 % | $ 37.8 M | USA |
 |
Personalis
PSNL
|
-31.12 | $ 15.9 | -0.31 % | $ 1.42 B | USA |
 |
Sotera Health Company
SHC
|
12.86 | $ 16.25 | -1.16 % | $ 4.61 B | USA |
 |
Quidel Corporation
QDEL
|
60.8 | $ 11.56 | -4.43 % | $ 487 M | USA |
 |
Centogene N.V.
CNTG
|
140.54 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Trinity Biotech plc
TRIB
|
88.73 | $ 5.88 | 10.08 % | $ 2.11 B | Irlanda |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-656.53 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-147.83 | - | 0.12 % | $ 80.1 M | China |
 |
Aspira Women's Health
AWH
|
0.18 | - | -6.19 % | $ 10.5 M | USA |
 |
Check-Cap Ltd.
CHEK
|
120.45 | - | - | $ 9.42 M | Israel |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 26.91 | 0.9 % | $ 602 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 132.17 | -2.35 % | $ 7.9 B | USA |
 |
Organovo Holdings
ONVO
|
1259.6 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
74.14 | - | -16.95 % | $ 1.54 M | USA |
 |
PerkinElmer
PKI
|
3.33 | - | -0.91 % | $ 14.7 B | USA |
 |
Soleno Therapeutics
SLNO
|
4.64 | - | - | $ 2.69 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Waters Corporation
WAT
|
25.09 | $ 476.29 | -0.09 % | $ 28.4 B | USA |
 |
Exagen
XGN
|
-114.34 | $ 5.26 | -25.92 % | $ 113 M | USA |
 |
Celcuity
CELC
|
-176.06 | $ 67.13 | -4.11 % | $ 3.14 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 370.89 | -0.25 % | $ 30.9 B | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 101.65 | 0.63 % | $ 6.86 B | USA |
 |
Accelerate Diagnostics
AXDX
|
89.3 | - | -61.36 % | $ 2.46 M | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 664.97 | -1.18 % | $ 19.2 B | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 346.21 | -2.02 % | $ 17.2 B | USA |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 750.2 | -0.69 % | $ 36.1 B |  Schweiz |
 |
Danaher Corporation
DHR
|
6.88 | $ 236.19 | 0.46 % | $ 168 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.16 | $ 30.39 | -1.32 % | $ 28.8 B | Niderland |
 |
RadNet
RDNT
|
-1.71 | $ 77.91 | -0.6 % | $ 5.86 B | USA |
 |
Senseonics Holdings
SENS
|
-113.19 | $ 10.05 | 2.55 % | $ 419 M | USA |